Biorepository for investigation of diseases of the lung (BRINDL) - phase II

Active Cooperative Agreement Awarded Last action

Award ID
U01HL148861
Recipient
Awarding agency
Obligated
$9,720,885

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 72% complete
Originally
Place of performance
Rochester, NY 14642, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $452,760
Amendment $462,000
Amendment $396,315
Amendment -$396,315
Amendment $462,000
Amendment $0
Amendment $1,375,880
Amendment $1,375,880
Amendment $0
Amendment $1,375,880
Amendment $125,000
Amendment $1,357,803
Amendment $1,375,880
Original award $1,357,802
Show all 14

Subawards

Subrecipient Amount Awarded
National Disease Research Interchange BRINDL - Phase III $61,526
Seattle Children's Hospital BioRepository for INvestigation of Diseases of the Lung (BRINDL) - Phase III $72,906
National Disease Research Interchange Biorepository for Investigation of Diseases of the Lung (BRINDL) - Phase II $415,139
Seattle Children's Hospital Biorepository for INvestigation of Diseases of the Lung (BRINDL) - Phase II $364,951

Quick answers

Who received award U01HL148861?

U01HL148861 was awarded to University Of Rochester by National Heart Lung and Blood Institute (National Institutes of Health) on August 21, 2019.

How much is award U01HL148861 worth?

$9,720,885 has been obligated on U01HL148861.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award